Senior insider sale
Chief Executive Officer at VIR BIOTECHNOLOGY, INC. — senior position signals high conviction
$282.6K
33.80K shares
What this filing means
DE BACKER MARIANNE plans to sell 33.80K shares of VIR BIOTECHNOLOGY, INC. valued at approximately $282.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/24/2026ACC: 0001959173-26-001446
DirectorOfficer· Chief Executive Officer
Since Feb 2026
33.80K
Shares to sell
$282.6K
Approx. market value
14.76K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/23/2026
14.76KTotal acquired14.76K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/23/2026 | Restricted Stock Vesting Compensation | 14.76K | — |
| Total | 14.76K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
19.04K
Market value
$141.9K
2/23/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
14.76K
Market value
$140.7K
2/24/2026
Total
Units
33.80K
Value
$282.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/23/2026 | 19.04K | $141.9K | — | Completed |
| Planned — Approximate Date | ||||
2/24/2026 | 14.76K | $140.7K | NASDAQ | Planned |
| Total | 33.80K | $282.6K | ||